Repository logo
 
Publication

From Pyridine to (-)-Agelastatin A

dc.contributor.authorVale, João R.
dc.contributor.authorFortunato, Milene A. G.
dc.contributor.authorAndrade, Késsia H. S.
dc.contributor.authorRocha, Ângelo M. R.
dc.contributor.authorAfonso, Carlos
dc.contributor.authorSiopa, Filipa
dc.date.accessioned2024-01-19T17:27:12Z
dc.date.available2024-01-19T17:27:12Z
dc.date.issued2023-06
dc.date.updated2023-10-25T17:18:01Z
dc.description© 2023 The Authors. Advanced Synthesis & Catalysis published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cite.pt_PT
dc.description.abstract(−)-Agelastatin A was synthetized employing a flow photorearrangement of a pyridinium salt, constructing in one step the cyclopentene core possessing the desired functionalities and relative configurations. A flow enzymatic kinetic resolution of the resulting bicyclic vinyl aziridine delivered the enantiopure precursor to the natural product. This total synthesis required the use of a single protective group. Two novel agelastatin N3-derivatives were synthesized and their cytotoxicity evaluated against a series of cancer cell lines, which corroborated the importance of unsubstituted N3 in the biological activity of (−)-agelastatin A.pt_PT
dc.description.sponsorshipThe authors acknowledge Fundação para a Ciência e Tecnologia (FCT) for financial support (2022.08559.PTDC, UIDB/04138/2020, UIDP/04138/2020, SFRH/BD/120119/2016, SFRH/BD/148211/2019 and 2021.06598.BD). The project leading to this application has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 951996. The NMR spectrometers are part of the National NMR Network (PT NMR) are partially supported by Infrastructure Project No. 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationVale JR, Fortunato MAG, Andrade KHS, Rocha ÂMR, Afonso CAM, Siopa F. From pyridine to (−)‐agelastatin a. Adv Synth Catal [Internet]. 4 de julho de 2023;365(13):2240–7. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/adsc.202300560pt_PT
dc.identifier.doi10.1002/adsc.202300560pt_PT
dc.identifier.issn1615-4150
dc.identifier.issn1615-4169
dc.identifier.slugcv-prod-3290188
dc.identifier.urihttp://hdl.handle.net/10451/61993
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWileypt_PT
dc.relationResearch Institute for Medicines
dc.relationResearch Institute for Medicines
dc.relationDiazo-free C-H insertion of acylsilanes towards new cyclic silanes.
dc.relationSynthetic valorization of bio-renewable resources to bioactive highly functionalized molecules
dc.relationChemical engineered extracts of Portuguese biorenewable resources to the synthesis of diverse natural products hybrids towards new bioactive entities
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1002/adsc.202300560pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleFrom Pyridine to (-)-Agelastatin Apt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleDiazo-free C-H insertion of acylsilanes towards new cyclic silanes.
oaire.awardTitleSynthetic valorization of bio-renewable resources to bioactive highly functionalized molecules
oaire.awardTitleChemical engineered extracts of Portuguese biorenewable resources to the synthesis of diverse natural products hybrids towards new bioactive entities
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/2022.08559.PTDC/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04138%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04138%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F120119%2F2016/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F148211%2F2019/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//2021.06598.BD/PT
oaire.citation.endPage2247pt_PT
oaire.citation.issue13pt_PT
oaire.citation.startPage2240pt_PT
oaire.citation.titleAdvanced Synthesis & Catalysispt_PT
oaire.citation.volume365pt_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStreamOE
person.familyNameVale
person.familyNameGamito Fortunato
person.familyNameMateus Afonso
person.familyNameDeslgado Siopa
person.givenNameJoão
person.givenNameMilene Andreia
person.givenNameCarlos Alberto
person.givenNameFilipa Alexandra
person.identifier.ciencia-idDF1D-6E5E-9EE7
person.identifier.ciencia-idAA16-A885-3ABD
person.identifier.ciencia-id6319-2E4C-5BE1
person.identifier.ciencia-id6A16-150F-A9F9
person.identifier.orcid0000-0003-0411-9618
person.identifier.orcid0000-0003-1072-0709
person.identifier.orcid0000-0002-7284-5948
person.identifier.orcid0000-0002-4514-9154
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.cv.cienciaid6A16-150F-A9F9 | Filipa Alexandra Delgado Siopa
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication70df5545-6eb8-4c2b-ab3b-e10a2ab6ad69
relation.isAuthorOfPublicationfd831776-6563-41ed-b777-1cec2703f955
relation.isAuthorOfPublication811958c9-3280-45c4-bff2-dd54318875d0
relation.isAuthorOfPublicationa64b1654-ee75-40fa-b039-b9829c65af3a
relation.isAuthorOfPublication.latestForDiscovery811958c9-3280-45c4-bff2-dd54318875d0
relation.isProjectOfPublicationec70d951-1081-4692-9e9b-307d2a6b23b4
relation.isProjectOfPublicationbb00962c-ed82-4d7a-bc37-61df49767d93
relation.isProjectOfPublicationa21e6964-b01b-421e-9356-1ff6579cdd5c
relation.isProjectOfPublicationac084f8a-6cfb-45eb-8266-5aa8dd189fb4
relation.isProjectOfPublication5c1d2179-5b8c-4d90-b3d9-5ba953cacf3d
relation.isProjectOfPublication6c16aa8f-7c66-45d9-ba48-31cac9cc6451
relation.isProjectOfPublication.latestForDiscoveryac084f8a-6cfb-45eb-8266-5aa8dd189fb4

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-Vale-From_Pyridine_to_Agelastatin_A.pdf
Size:
4.72 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.2 KB
Format:
Item-specific license agreed upon to submission
Description: